Showing 1 - 3 results of 3 for search 'Fengming Tang', query time: 0.01s Refine Results
  1. 1
    Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

    Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study by Jesús Medina, Kamlesh Khunti, Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Eric Wittbrodt, Filip Surmont

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme

    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study

    Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study by Jesús Medina, Peter Fenici, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Suzanne V Arnold, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: